The Latest Cardiac and Vascular News
CHICAGO, Sept. 7, 2017 /PRNewswire/ — BIOLIFE4D announced it filed a $50 million initial public offering with the Securities and Exchange Commission (SEC) under Regulation A+ rules, allowing everyday investors to help the company bring its groundbreaking cardiac tissue regeneration and organ replacement process to market. Chicago-based BIOLIFE4D is a pioneering biotech company focused on leveraging […]
KIRKLAND, Wash.–(BUSINESS WIRE)–Cardiac Insight, Inc., a U.S. developer of wearable medical devices and diagnostic software, announced today that the company continues to experience a steady beat of market traction and industry endorsement with a recent infusion of $4.5 million into their new C-1 round of funding, currently capped at $10 […]
REDWOOD CITY, Calif.–(BUSINESS WIRE)–HeartFlow, Inc. today announced that Anthem Blue Cross Blue Shield, Blue Shield of California, and Blue Cross and Blue Shield of Alabama have each issued a positive medical policy for the HeartFlow® FFRct Analysis, a first-of-its-kind noninvasive technology that helps clinicians diagnose and treat patients with suspected coronary artery […]
Looks like the FDA will be increasing the user fees for fiscal 2018 Most FDA user fees set to rise 33% AUGUST 30, 2017 BY BRAD PERRIELLO, MassDevice The latest user fee authorization enacted last week has most of the fees medical device makers pay the FDA to review its products rising […]
DANVERS, Mass., Aug. 28, 2017 (GLOBE NEWSWIRE) — Abiomed, Inc. (NASDAQ:ABMD), a leading provider of breakthrough heart support and recovery technologies, announced today that it has accepted the resignation of its Chief Financial Officer, Michael Tomsicek, effective August 24, 2017. After two years, Mr. Tomsicek is leaving the Company to pursue other […]
NASHUA, N.H., Aug. 28, 2017 /PRNewswire/ — Resonetics announced today its acquisition of Aduro Laser, an emerging leader in laser processing of tubular components for the medical device industry. In just four years, Aduro has established an innovative business model and proprietary technology to shorten lead times dramatically, enabling customers to iterate rapidly and […]
Valencia, CA – August 28, 2017 – SetPoint Medical, a clinical-stage biomedical technology company developing a bioelectronic therapy for chronic inflammatory diseases, announced today that it has secured $30 million in Series D equity financing. The Series D financing will provide SetPoint with funding to further advance the clinical development of […]
ALAMEDA, Calif., Aug. 24, 2017 /PRNewswire/ — Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the following upcoming investor conferences: Event: Wells Fargo 2017 Healthcare Conference Location: Boston, MA at the Westin Boston Waterfront Date: Thursday, September 7, 2017 Time: 1:40pm ET / 10:40am PT Event: Morgan […]
Ra Medical finally received FDA approval this year after three years, now they will be shooting for an IPO. Ra Medical CEO Irwin aims for Feb 2018 IPO AUGUST 24, 2017 BY FINK DENSFORD, MassDevice In May, Ra Medical received a nod from the FDA for its Dabra arteriosclerosis laser, clearing it for use in the […]
TEL AVIV, ISRAEL–(Marketwired – August 22, 2017) – InspireMD, Inc. (NYSE American: NSPR) (NYSE MKT: NSPR) (“InspireMD” or the “Company”), a leader in embolic prevention systems (EPS) / thrombus management technologies and neurovascular devices, today announced it received a letter from the NYSE American on August 17, 2017 indicating that InspireMD does not […]
